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What is the role of herpes virus
serology in sexually transmitted 
disease screening?
z Evidence summary
An effective screening test for HSV would
need to identify those with HSV infection
before substantial morbidity resulted, and
effective interventions would need to be
available for use in the asymptomatic
stage. Screening for HSV-2 must also con-
sider the psychosocial impact of serologic
diagnosis in those without symptoms, as a
qualitative study showed both negative
and positive emotional responses in those
with positive serology, with short-term
emotional responses described as surprise,
denial, confusion, distress, disappoint-
ment, and sense of relief.1 Patients also
expressed fear of partner notification, 
concern for transmission to newborns, and
concern for social stigma. 
Screening for herpes simplex virus type 2
(HSV-2) infection with antibody testing is not
indicated for asymptomatic adults (strength
of recommendation [SOR]: B, prevalence
studies and predictive value of testing).
Screening with serology testing is not 
indicated for asymptomatic pregnant
women (SOR: B, 1 cohort study).
You may consider offering testing to
asymptomatic patients with an HSV-
positive partner, patients with HIV infection,
and those with current or recent sexually 
transmitted infection or high-risk behavior
(SOR: C, expert opinion and 1 case 
control study with extrapolation of 
results).
Counsel patients that the diagnostic
gold standard remains viral culture 
or PCR testing of active lesions
Early in my practice, a couple came to my
office demanding serology testing for HSV
after resolution of a new genital lesion. The
results of the non-type-specific HSV serolo-
gy led to more questions than answers due
to cross-reactivity between virus types.
Even with the newer type-specific glyco-
protein enzyme immunoassays for HSV 1
and 2, I reserve serologic testing for 
specific situations, as outlined in this 
review, and when recurrent genital signs or
symptoms of unclear cause present with
negative viral culture results. I counsel
patients that the diagnostic gold standard
remains viral culture or PCR testing of
active lesions. The best course of action 
for most asymptomatic patients remains
sexually transmitted disease counseling 
and returning to the clinic for viral culture if
a suspicious lesion returns.
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Reserve serologic
testing for those
with HIV infection,
HSV-positive 
partners, current
or recent STI,
or high-risk
behaviors
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Pre- and post-test counseling must
accompany testing as negative emotional
or psychological responses are amenable to
this intervention. A consideration for
screening decisions is the positive predic-
tive value (PPV) of testing for the specific
patient, which ranges from 58% (in a
British population with 4% prevalence) to
90% (in a population with 22% preva-
lence taken from sexually transmitted 
disease clinics in the Netherlands).2 (A PPV
of 58% means that only 58% of women
with a positive test actually had the dis-
ease, and 42% were false-positive).
The primary goal for screening preg-
nant women is prevention of neonatal
transmission of HSV. A prospective obser-
vational study3 of 7046 women found that
acquisition of HSV-2 during pregnancy
was asymptomatic in 74% of 94 cases. No
increase in neonatal or pregnancy-related
morbidity was seen for those patients who
had seroconverted by the time of labor.
The main benefit of serology testing during
pregnancy has been to identify patients
with asymptomatic infection and counsel
them on reporting new symptoms for eval-
uation and treatment. 
Another prospective cohort study4
identified seropositive pregnant women
with no history of genital herpes. Forty-
three of 264 (16%) of these women were
able to identify and report clinical HSV to
their physician during the pregnancy.
Testing of asymptomatic patients with
HSV-2 serology and counseling has been
recommended by some experts5 for moti-
vated patients with current or recent 
sexually transmitted infection or HIV
infection and for partners of HSV-positive
patients.6 Screening could give those iden-
tified the opportunity to learn to recognize
symptoms, decrease transmission, and
understand risks of acquiring HIV or other
sexually transmitted infections. Patients
screening negative might have heightened
awareness to susceptibility and reinforce
lifestyle changes.6 Success of HSV preven-
tion strategies is reviewed elsewhere.7
Recommendations from others
The Centers for Disease Control and
Prevention, the United States Preventive
Services Task Force, and the American
Academy of Family Physicians do not 
recommend screening asymptomatic
adults for HSV infection.7,8 The American
College of Obstetricians and Gynecologists
does not recommend routine screening of
pregnant women for HSV.9
R E F E R E N C E S
1. Melville J, Sniffen S, Salazar L, et al. Psychosocial impact
of serological diagnosis of herpes simplex virus type 2: 
a qualitative assessment. Sex Trans Infect 2003; 79:
280–285.
2. Krantz I, Lowhagen G, Ahlberg B, Nilstun T. Ethics of
screening for asymptomatic herpes virus type 2 infection.
BMJ 2004; 329:618–621.
3. Brown Z, Selke S, Zeh J, et al. The acquisition of herpes
simplex virus during pregnancy. N Engl J Med 1997;
337:509–516.
4. Frenkel L, Garratty E, Ping S, et al. Clinical reactivation of
herpes simplex virus type 2 infection in seropositive 
pregnant women with no history of genital herpes. Ann Int
Med 1993; 118:414–418.
5. Centers for Disease Control and Prevention. Incorporating
HIV prevention into medical care of persons living with HIV:
recommendations of CDC, the Health Resources and
Services Administration, the National Institutes of Health,
and the HIV Medicine Association of the Infectious
Diseases Society of America. MMWR Recomm Rep 2003;
52(RR-12).
6. Centers for Disease Control and Prevention. Diseases
Characterized by Genital Ulcers. Sexually Transmitted
Diseases Guidelines. MMWR Recomm Rep 2002; 51(RR-
6):11–25.
7. Screening for genital herpes simplex. Rockville, Md: 
US Preventive Task Force updated March 2005. Available
at: www.ahrq.gov/clinic/uspstf05/herpes/herpesup.htm.
Accessed on April 18, 2006.
8. American Academy of Family Physicians. Summary of pol-
icy recommendations for periodic health examinations.
Leawood, Kan: American Academy of Family Physicians;
2004. 15pp.
9. American College of Obstetricians and Gynecologists.
Guidelines for Perinatal Care. 5th ed. Elk Grove, Ill: AAP;
Washington, DC: ACOG; 2002.
 
